Alpine Immune Sciences Statistics Share Statistics Alpine Immune Sciences has 68.6M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 68.6M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 47.88M Failed to Deliver (FTD) Shares 7 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 2.44M, so 0% of the outstanding
shares have been sold short.
Short Interest 2.44M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1.34
Valuation Ratios The PE ratio is -29.61 and the forward
PE ratio is -28.88.
Alpine Immune Sciences's PEG ratio is
0.47.
PE Ratio -29.61 Forward PE -28.88 PS Ratio 16.19 Forward PS 496.2 PB Ratio 2.91 P/FCF Ratio -11.99 PEG Ratio 0.47
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Alpine Immune Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.86,
with a Debt / Equity ratio of 0.03.
Current Ratio 7.86 Quick Ratio 7.87 Debt / Equity 0.03 Debt / EBITDA -0.23 Debt / FCF -0.12 Interest Coverage -451.53
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $414.62K Profits Per Employee $-226.65K Employee Count 142 Asset Turnover 0.15 Inventory Turnover -484.46
Taxes Income Tax 103K Effective Tax Rate -0.32%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.97, so Alpine Immune Sciences's
price volatility has been higher than the market average.
Beta 0.97 52-Week Price Change n/a 50-Day Moving Average 53.07 200-Day Moving Average 26.53 Relative Strength Index (RSI) 83.31 Average Volume (20 Days) 2,371,991
Income Statement In the last 12 months, Alpine Immune Sciences had revenue of 58.88M
and earned -32.18M
in profits. Earnings per share was -0.64.
Revenue 58.88M Gross Profit -22.03M Operating Income -44.25M Net Income -32.18M EBITDA -43.67M EBIT -31.98M Earnings Per Share (EPS) -0.64
Full Income Statement Balance Sheet The company has 43.92M in cash and 9.91M in
debt, giving a net cash position of 34.01M.
Cash & Cash Equivalents 43.92M Total Debt 9.91M Net Cash 34.01M Retained Earnings -256.14M Total Assets 373.65M Working Capital 276.01M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -79.01M
and capital expenditures -487K, giving a free cash flow of -79.5M.
Operating Cash Flow -79.01M Capital Expenditures -487K Free Cash Flow -79.5M FCF Per Share -1.59
Full Cash Flow Statement Margins Gross margin is -37.41%, with operating and profit margins of -75.16% and -54.66%.
Gross Margin -37.41% Operating Margin -75.16% Pretax Margin -54.49% Profit Margin -54.66% EBITDA Margin -74.18% EBIT Margin -75.16% FCF Margin -135.03%
Dividends & Yields ALPN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ALPN.
Price Target $65 Price Target Difference 0% Analyst Consensus Hold Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 25, 2017. It was a
backward
split with a ratio of 1:4.
Last Split Date Jul 25, 2017 Split Type backward Split Ratio 1:4
Scores Altman Z-Score 64.92 Piotroski F-Score 3
